John Sweetenham, MD, PhD

Editorials by John Sweetenham, MD

Editorial

Online oncology: Building (dis)connections

HemOnc Today, May 10, 2018
John Sweetenham, MD
The online resources available to us and to our patients to enhance cancer care are expanding at a dizzying rate. Leveraging digital technology…
Editorial

Clinical pathways: A new target

HemOnc Today, April 10, 2018
John Sweetenham, MD
It is now widely accepted that adherence to evidence-based clinical pathways for cancer treatment has the potential to reduce variability, improve…
Editorial

A sad week

HemOnc Today, March 10, 2018
John Sweetenham, MD
On February 2, Jon Huntsman Sr., the founder of Huntsman Cancer Institute at The University of Utah, passed away peacefully at home. Many tributes…
Editorial

Don’t give up the day job

HemOnc Today, February 10, 2018
John Sweetenham, MD
Anyone who has been reading the peer-reviewed oncology literature or publications like HemOnc Today will be familiar with the increasing problem of…
Editorial

Putting the CAR Ts before the horse

HemOnc Today, January 10, 2018
John Sweetenham, MD
The daily flood of sponsored and nonsponsored content often reports the same studies, new FDA approvals, latest meetings and so on with such a degree…
Editorial

Tobacco, alcohol and cancer: Not always black and white

HemOnc Today, December 10, 2017
John Sweetenham, MD
The mother of a friend and former colleague of mine was recently admitted to our facility for evaluation of a lung mass. An initial biopsy indicated…
Editorial

The preservation of affordable cancer care

HemOnc Today, November 10, 2017
John Sweetenham, MD
In a 6-month period characterized by political chaos, there have been plenty of reasons to become disheartened by the apparent lack of dialogue…
Editorial

Physical activity and cancer outcomes: Growing evidence for the oncologist

HemOnc Today, October 10, 2017
John Sweetenham, MD
I have been running regularly throughout most of my adult life, beginning at school, through medical school and to the present day. My runs have…
Editorial

The pathway to value: A complicated journey begins with one step

HemOnc Today, September 10, 2017
John Sweetenham, MD
The intensity of coverage of drug costs and value in oncology care in peer-reviewed journals, the popular oncology press, the media in general and…
Editorial

Stem cell transplantation and CMS: Extreme (hospital at) home makeover

HemOnc Today, August 10, 2017
John Sweetenham, MD
“It’s no wonder that truth is stranger than fiction. Fiction has to make sense.” – Mark Twain